Hemcheck obtains CE mark for its new product for the blood gas market
January 19, 2022 10:31 amHemcheck’s new product for the blood gas market is now CE marked. The bgs-Test is a hemolysis test which can receive a significantly larger amount…
Hemcheck’s new product for the blood gas market is now CE marked. The bgs-Test is a hemolysis test which can receive a significantly larger amount…
Hemcheck Sweden AB has received a so-called “Intention to Grant” from the European Patent Office, “EPO”, regarding the patent application for its filter solution. This…
University Hospital Centre Zagreb have successfully finalized two evaluation studies of Hemcheck’s products at the Department of Laboratory Diagnostics. These formal evaluations preliminary results confirm…
Hemcheck has finalised the verification phase regarding the new product for the blood gas market and is now entering a final validation phase, where usability…
Hemcheck Sweden AB has received an evaluation order from the International Agency for Research on Cancer (IARC) regarding reader and disposable tests (s-Test). The order…
Hemcheck Sweden AB has signed a 3-month evaluation agreement with potential continuation into a 36-month long distribution agreement with Sanova Pharma GesmbH (”Sanova”), regarding the…
Hemcheck Sweden AB has signed an exclusive distribution agreement with Cambridge Life Sciences Ltd (“CLS”), a leading manufacturer and distributor of assays, laboratory and medical…
An abstract based on the studies that were performed earlier this year at Hospital de la Santa Creu i Sant Pau, Barcelona, has both been…
Hemcheck Sweden AB has received a new follow up order from the Foundation for Innovative New Diagnostics (FIND) regarding delivery of reader and one-time tests…
An article has been published in the Journal of Laboratory Medicine highlighting the importance of hemolysis detection in blood gas analysis as well that Hemcheck…